BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 16, Issue 1
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (3215)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-5) series.
Item 
Count 
PDF65
WORD18
HTML1547
Figures (1-4)180
Tables (1-5)201
 Sum=2011
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse135
Download388
 Sum=523
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse226
Download365
 Sum=591
Jan 27, 2024 (publication date) through Dec 1, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Michalczuk MT, Longo L, Keingeski MB, Basso BS, Guerreiro GTS, Ferrari JT, Vargas JE, Oliveira CP, Uribe-Cruz C, Cerski CTS, Filippi-Chiela E, Álvares-da-Silva MR. Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease. World J Hepatol 2024; 16(1): 75-90 [PMID: 38313241 DOI: 10.4254/wjh.v16.i1.75]
URL: https://www.wjgnet.com/1007-9327/full/v16/i1/75.htm
Number Citing Articles
1
Felipe Schütz, Larisse Longo, Melina Belén Keingeski, Eduardo Filippi-Chiela, Carolina Uribe-Cruz, Mário Reis Álvares-da-Silva. Lipophagy and epigenetic alterations are related to metabolic dysfunction-associated steatotic liver disease progression in an experimental model. World Journal of Hepatology 2024; 16(12): 1468-1479 doi: 10.4254/wjh.v16.i12.1468
2
Larisse Longo, Gabriel Guerreiro, Luiza Behrens, Matheus Pereira, Carlos Pinzon, Carlos Cerski, Carolina Uribe‑Cruz, Mário Álvares‑da‑Silva. Rifaximin prophylaxis in MASLD‑hepatocellular carcinoma: Lessons from a negative animal model. Biomedical Reports 2024; 22(1) doi: 10.3892/br.2024.1882
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345